Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism

被引:53
|
作者
Louis, JM
Wondrak, EM
Kimmel, AR
Wingfield, PT
Nashed, NT
机构
[1] NIH, Phys Chem Lab, NIDDK, Bethesda, MD 20892 USA
[2] NIH, Cellular & Dev Biol Lab, NIDDK, Bethesda, MD 20892 USA
[3] NIH, Lab Protein Express, NIAMS, Bethesda, MD 20892 USA
[4] NIH, NIDDK, Lab Bioorg Chem, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.274.33.23437
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously it was demonstrated using a model precursor that processing at the N terminus of the HIV-1 protease (PR) precedes processing at its C terminus. We now show the expression, purification, and kinetics of the autoprocessing reaction of a PR precursor linked to 53 amino acids of the native flanking transframe region (Delta TFP-p6(pol)) of Gag-Pol and containing its two native cleavage sites. The PR contains the two cysteine residues exchanged to alanines, mutations that do not alter the kinetics or the structural stability of the mature PR. Delta TFP-p6(pol)-PR, which encompasses the known PR inhibitor sequence Glu-Asp-Leu within Delta TFP, undergoes cleavage at the Delta TFP/p6(pol) and p6(pol)/PR sites in two consecutive steps to produce the mature PR. Both Delta TFP-p6(pol)-PR and p6(pol)-PR exhibit low intrinsic enzymatic activity. The appearance of the mature PR is accompanied by a large increase in catalytic activity, It follows first-order kinetics in protein concentration with a rate constant of 0.13 +/- 0.01 min(-1) in 0.1 ar acetate at pH 4.8, The pH-rate profile for the observed first-order rate constant is bell-shaped with two ionizable groups of pK(a) 4.9 and 5.1. The rate constant also exhibits approximately 7-fold higher sensitivity to urea denaturation as compared with that of the mature PR, suggesting that the cleavage at the N terminus of the PR domain from the precursor leads to the stabilization of the dimeric structure.
引用
收藏
页码:23437 / 23442
页数:6
相关论文
共 50 条
  • [31] HIV-1 protease inhibitors
    Eron, JJ
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S160 - S170
  • [32] HIV-1 protease inhibitors
    不详
    DRUG DISCOVERY TODAY, 2001, 6 (08) : 438 - 439
  • [33] INHIBITORS OF HIV-1 PROTEASE
    DREYER, GB
    CARR, T
    LAMBERT, DM
    TOMASZEK, T
    MEEK, T
    CACCIAVILLANI, E
    PETTEWAY, SR
    MOORE, M
    DEBOUCK, C
    METCALF, BW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 83 - MEDI
  • [34] Activation mechanism of pepsinogen as compared to the processing of HIV protease gag-pol precursor protein
    Koelsch, G
    Loy, J
    Lin, XL
    Tang, J
    ASPARTIC PROTEINASES: RETROVIRAL AND CELLULAR ENZYMES, 1998, 436 : 245 - 252
  • [35] HIV-1 PROTEASE INHIBITORS - THEIR DEVELOPMENT, MECHANISM OF ACTION AND CLINICAL POTENTIAL
    PILLAY, D
    BRYANT, M
    GETMAN, D
    RICHMAN, DD
    REVIEWS IN MEDICAL VIROLOGY, 1995, 5 (01) : 23 - 33
  • [36] Investigating the folding mechanism of HIV-1 protease, a dimeric β-barrel protein
    Fitzgerald, AA
    Wu, Y
    Kundu, A
    Matthews, CR
    PROTEIN SCIENCE, 2004, 13 : 107 - 107
  • [37] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [38] Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor
    Ishima, Rieko
    Torchia, Dennis A.
    Louis, John M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (23) : 17190 - 17199
  • [39] Evaluating the potency of HIV-1 protease inhibitors in blocking the initial step of HIV gagpol processing
    Davidoff, Katharine
    Soule, Erin
    Daniels, Sarah
    Davis, David
    Yarchoan, Robert
    FASEB JOURNAL, 2011, 25
  • [40] HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein
    Kim, Jiyoung
    Yoon, Jee-Hyun
    Kim, Yeon-Soo
    PLOS ONE, 2013, 8 (11):